RPG Life Sciences Partners Archerchem for Naprosyn ES Launch in India

RPG Life Sciences (RPG LS) has partnered with Archerchem Healthcare to launch Naprosyn ES, a combination of Naproxen and Esomeprazole, for the first time in India. This product offers an effective anti-inflammatory solution with gastro-protection, addressing a significant unmet need for patients requiring long-term NSAID therapy, especially those at risk of gastrointestinal complications. RPG LS will exclusively market and distribute the product nationwide, while Archerchem will be the exclusive supplier. The launch leverages RPG LS's R&D-driven approach, strong brand recall of Naprosyn, and extensive distribution network, aligning with its strategy to build a differentiated portfolio in chronic therapy segments. The co-developed formulation aims to improve patient compliance and enable safer long-term pain management.